Skip to main content
. 2012 Nov 2;304(2):H328–H336. doi: 10.1152/ajpheart.00500.2012

Fig. 5.

Fig. 5.

hE-Hb-B10 reduces plasma alanine aminotransferase (ALT) activity in mouse models of chronic hemolytic anemia. A: plasma ALT activity in AA and SS mice was measured after daily intraperitoneal treatment with PBS or hE-Hb-B10 for 3 wk. B: plasma ALT activity in Ctrl and HS mice was measured after daily intraperitoneal treatment with PBS or hE-Hb-B10 for 3 wk. Data are means ± SE. *P = 0.003, AA mice compared with SS mice, and P < 0.0001, Ctrl mice compared with HS mice; #P ≤ 0.02, PBS-treated compared with B10-treated mutant mice.